Government Investigation Finds Flaws In the FDA’s Orphan Drug Program
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The Food and Drug Administration has failed to ensure
Read More(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The Food and Drug Administration has failed to ensure
Read More(By Alia Paavola for Becker’s Hospital Review ) The FDA is not only seeing an increased incidence of drug shortages,
Read More(By Meghana Keshavan for ST A T) V ickie Moored can walk again. Her words don’t slur, her vision isn’t
Read More(By Rob Stein for NPR) The Food and Drug Administration announced Thursday that it will seek a ban on the
Read More(By Alia Paavola for Becker’s Hospital Review ) Novartis will stop working toward FDA approval for its biosimilar of rituximab,
Read More(By Ike Swetlitz for ST A T) W ASHINGTON — President Trump on Thursday blasted pharmaceutical companies for having “rigged
Read More(By Alia Paavola for Becker’s Hospital Review ) An executive of the new hospital-owned drug company Civica Rx said he
Read More(By Rachel Bluth for Kaiser Health News) Everyone has seen the ads or the products on the shelves. A dietary
Read More(By Megan Knowles for Becker’s Hospital Review ) FDA Commissioner Scott Gottlieb, MD, on Sept. 14 outlined the agency’s plan
Read MoreFDA is extending the expiration date of some lots of EpiPen and its authorized generic to combat the national shortage
Read More